• Sigma Healthcare Ltd requests trading halt pending announcements on shareholder meeting outcomes
• Meetings relate to merger between Sigma and Chemist Warehouse
• Halt to allow Sigma to manage continuous disclosure obligations

Sigma Healthcare Ltd has requested a trading halt on its shares (ASX: SIG) pending the release of announcements regarding the outcome of shareholder meetings related to its proposed merger with Chemist Warehouse. The trading halt has been requested to allow Sigma to manage its continuous disclosure obligations and ensure that its shares are not trading on an uninformed basis. The meetings in question are the Sigma shareholder meeting and the Chemist Warehouse scheme meeting, both of which are being held today. The passing of certain resolutions at these meetings are conditions precedent to the implementation of the merger between the two companies. Sigma has requested the trading halt to continue until the earlier of the commencement of trading on 30 January 2025 or when Sigma makes both of the intended announcements.